Anti‐CD22 and anti‐CD79b antibody‐drug conjugates preferentially target proliferating B cells

por Fuh, Franklin K, Looney, Caroline, Li, Dongwei, Poon, Kirsten A, Dere, Randall C, Danilenko, Dimitry M, McBride, Jacqueline, Reed, Chae, Chung, Shan, Zheng, Bing, Mathews, William Rodney, Polson, Andrew, Prabhu, Saileta, Williams, Marna
Publicado 2017

Evaluation and use of an anti‐cynomolgus monkey CD79b surrogate antibody–drug conjugate to enable clinical development of polatuzumab vedotin

por Li, Dongwei, Lee, Donna, Dere, Randall C., Zheng, Bing, Yu, Shang‐Fan, Fuh, Franklin K., Kozak, Katherine R., Chung, Shan, Bumbaca Yadav, Daniela, Nazzal, Denise, Danilenko, Dimitry, Go, Mary Ann T., Williams, Marna, Polson, Andrew G., Poon, Kirsten Achilles, Prabhu, Saileta
Publicado 2019